Plexus Announces Fiscal Fourth Quarter and Fiscal Year 2026 Financial Results
Plexus raised its adjusted operating margin goal to 6.5%–7.0%, from its previous 6% goal.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Plexus (PLXS) reported fiscal fourth-quarter revenue of $1.427 billion, exceeding guidance, with higher earnings than a year earlier. For the quarter ended October 3, 2026, GAAP diluted EPS rose to $2.51 from $1.87, and operating margin increased to 6.0% from 5.0%. Fiscal 2026 revenue reached $4.965 billion, up 23%, while GAAP diluted EPS increased to $7.41 from $6.26.
Plexus forecasts first-quarter fiscal 2027 revenue of $1.410 billion to $1.460 billion and GAAP diluted EPS of $2.16 to $2.32. It expects fiscal 2027 revenue growth in the mid- to upper-teens and at least $100 million in free cash flow. Fourth-quarter manufacturing wins represent $290 million in annualized revenue when fully ramped. Fiscal 2026 free cash flow was negative $28.9 million. A further $100 million repurchase authorization is available to begin fiscal 2027.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Major point. Forward-looking: it has not happened yet and may not happen.Plexus raised its adjusted operating margin goal to 6.5%–7.0% from 6%, versus fiscal 2026's 6.2%.
- Moderate pointFourth-quarter revenue reached $1.427 billion, versus $1.058 billion a year earlier, exceeding $1.330–$1.380 billion guidance.
- Moderate pointFourth-quarter GAAP diluted EPS rose to $2.51 from $1.87 a year earlier, exceeding $2.18–$2.34 guidance.
- Moderate pointFourth-quarter GAAP operating margin increased to 6.0% from 5.0% a year earlier, exceeding 5.5%–5.9% guidance.
- Moderate pointFiscal 2026 revenue increased 23% year over year to $4.965 billion.
- Moderate pointFiscal 2026 GAAP diluted EPS rose to $7.41 from $6.26 in fiscal 2025.
- Moderate point. Forward-looking: it has not happened yet and may not happen.Manufacturing wins covered 36 programs, representing $290 million in annualized revenue when fully ramped into production.
- Moderate point. Forward-looking: it has not happened yet and may not happen.Plexus forecasts first-quarter revenue of $1.410–$1.460 billion, up 1% sequentially and 34% annually at midpoint.
- Moderate point. Forward-looking: it has not happened yet and may not happen.Plexus expects fiscal 2027 revenue growth in the mid- to upper-teens, with increasing operating margin.
- Moderate point. Forward-looking: it has not happened yet and may not happen.Plexus expects fiscal 2027 free cash flow of at least $100 million.
14 minor points
- Minor pointFiscal 2026 GAAP operating margin increased to 5.3% from 5.0% in fiscal 2025.
- Minor pointFourth-quarter adjusted operating margin of 6.7% and adjusted EPS of $2.84 exceeded guidance, excluding stock compensation.
- Minor pointFiscal 2026 adjusted EPS was $8.97, excluding $1.56 of stock-based compensation expense.
- Minor pointQualified opportunities increased 33% year over year to $4.9 billion.
- Minor point. Forward-looking: it has not happened yet and may not happen.The approved fiscal 2027 repurchase program provides an additional $100 million, entirely available to begin fiscal 2027.
- Minor pointFiscal 2026 return on invested capital reached 15.8%, versus 14.6%, exceeding the 9.0% capital cost.
- Minor pointFourth-quarter free cash flow was $6.4 million.
- Minor point. Forward-looking: it has not happened yet and may not happen.Fourth-quarter cash cycle improved to 62 days from 63 a year earlier; Plexus targets low-to-mid-60s days for fiscal 2027.
- Minor pointAmericas revenue rose to $456 million quarterly and $1,626 million annually, versus $336 million and $1,217 million.
- Minor pointAsia-Pacific revenue rose to $861 million quarterly and $2,898 million annually, versus $605 million and $2,393 million.
- Minor pointHealthcare/Life Sciences revenue rose to $512 million quarterly and $1,933 million annually, versus $424 million and $1,629 million.
- Minor pointIndustrial revenue rose to $691 million quarterly and $2,185 million annually, versus $461 million and $1,715 million.
- Minor pointAerospace/Defense quarterly revenue reached $224 million, versus $173 million annually and $233 million sequentially; annual revenue rose to $847 million.
- Minor pointEurope, Middle East and Africa annual revenue rose to $458 million from $440 million.
Negative
- Moderate pointFiscal 2026 free cash flow was negative $28.9 million, with capital expenditures exceeding operating cash flow.
- Moderate point. Forward-looking: it has not happened yet and may not happen.First-quarter GAAP EPS guidance of $2.16–$2.32 is below fourth-quarter $2.51; margin guidance is 5.5%–5.9%, versus 6.0%.
- Moderate pointTop 10 customers represented 56% of quarterly revenue, up 7 percentage points annually and 1 point sequentially.
- Minor pointFiscal 2026 top-10 customer concentration increased to 54% of revenue, up 5 percentage points annually.
- Minor pointEurope, Middle East and Africa quarterly revenue fell to $115 million from $119 million a year earlier.
- Minor point. Forward-looking: it has not happened yet and may not happen.Plexus anticipates a seasonal increase in cash cycle days in fiscal first-quarter 2027.
News Explained
Plexus repurchased
Key Figures
- Q4 revenue
- $1.427 billion
- Fiscal Q4 2026; above the $1.330–$1.380 billion guidance range
- Q4 GAAP diluted EPS
- $2.51
- Fiscal Q4 2026; above the $2.18–$2.34 guidance range
- Q4 non-GAAP diluted EPS
- $2.84
- Fiscal Q4 2026; above the $2.47–$2.63 guidance range
- Fiscal-year revenue
- $4.965 billion
- Fiscal 2026
- Fiscal-year non-GAAP diluted EPS
- $8.97
- Fiscal 2026
- Free cash flow
- $28.9 million usage
- Fiscal 2026
- Revenue guidance
- $1.410 billion to $1.460 billion
- Fiscal Q1 2027
- Non-GAAP diluted EPS guidance
- $2.46 to $2.62
- Fiscal Q1 2027
Previous Earnings Reports
-
Reported Q3 results and set Q4 revenue and EPS guidance as the immediate prior-quarter baseline.
-
Reported comparable fiscal fourth-quarter and full-year results, providing a year-over-year baseline.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
non-gaap financial
roic financial
weighted average cost of capital financial
stock-based compensation financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEENAH, WI, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Plexus Corp. (NASDAQ: PLXS) today announced financial results for our fiscal fourth quarter and fiscal year ended October 3, 2026, and guidance for our fiscal first quarter ending January 2, 2027.
- Reports fiscal fourth quarter revenue of
$1.427 billion , GAAP operating margin of6.0% and GAAP diluted EPS of$2.51 . - Reports fiscal 2026 revenue of
$4.965 billion , GAAP operating margin of5.3% and GAAP diluted EPS of$7.41 . - Reports fiscal fourth quarter non-GAAP operating margin of
6.7% and non-GAAP diluted EPS of$2.84 , excluding$0.33 of stock-based compensation expense. - Reports fiscal 2026 non-GAAP operating margin of
6.2% and non-GAAP diluted EPS of$8.97 , excluding$1.56 of stock-based compensation expense. - Initiates fiscal first quarter 2027 revenue guidance of
$1.410 billion to$1.460 billion with GAAP diluted EPS of$2.16 t o$2.32 , including$0.30 of stock-based compensation expense. Fiscal first quarter non-GAAP diluted EPS guidance of$2.46 t o$2.62 excludes stock-based compensation expense.
| Three Months Ended | |||||||||
| Oct 3, 2026 | Oct 3, 2026 | Jan 2, 2027 | |||||||
| Q4F26 Results | Q4F26 Guidance | Q1F27 Guidance | |||||||
| Summary GAAP Items | |||||||||
| Revenue (in billions) | |||||||||
| Operating margin | |||||||||
| Diluted EPS | |||||||||
| Summary Non-GAAP Items (1) | |||||||||
| Adjusted operating margin (2) | |||||||||
| Adjusted EPS (3) | |||||||||
| Return on invested capital (ROIC) | |||||||||
| Economic return | |||||||||
| (1) | Refer to Non-GAAP Supplemental Information tables for additional information regarding non-GAAP financial measures. | ||||||||
| (2) | Excludes stock-based compensation expense of approximately 70 bps for Q4F26 results, 60 bps for Q4F26 guidance and 50 bps for Q1F27 guidance. | ||||||||
| (3) | Excludes stock-based compensation expense, net of tax, of | ||||||||
Fiscal Fourth Quarter 2026 Information
- Won 36 manufacturing programs representing
$290 million in annualized revenue when fully ramped into production. - Generated free cash flow of
$6.4 million . - Purchased
$21.4 million of our shares at an average price of$254.32 per share, completing the 2026 Share Repurchase Program. The 2027 Share Repurchase Program was approved by Plexus' Board of Directors in August 2026 for an additional$100 million . The entirety of the 2027 Share Repurchase Program is available to begin fiscal 2027.
Fiscal Year 2026 Information
- Produced ROIC of
15.8% , representing an economic return of 680 basis points above our weighted average cost of capital of9.0% . - Delivered cash cycle of 62 days.
- Purchased
$85.0 million of our shares at an average price of$199.68 per share.
Todd Kelsey, President and Chief Executive Officer, “Plexus delivered an outstanding fiscal 2026 that exceeded expectations, achieving record revenue of
Mr. Kelsey added, “In support of sustaining our diversified and accelerating growth momentum, our go-to-market team generated robust quarterly manufacturing wins of
Mr. Kelsey continued, “Our culture is foundational to our success and embodied by our team as they live our vision to help create the products that build a better world. In fiscal 2026, our global team contributed approximately 35,000 paid volunteer time off hours to our local communities and the Plexus Community Foundation donated
David Abuhl, Senior Vice President and Chief Financial Officer, commented, “Plexus leveraged significant revenue growth, and the dividends from our ongoing operational efficiency investments and continuous improvement culture, to drive fiscal 2026 non-GAAP operating margin of
Mr. Abuhl continued, “Amidst further revenue growth acceleration, working capital discipline was outstanding, with a fiscal fourth quarter cash cycle of 62 days. While we anticipate a typical seasonal increase in cash cycle days for our fiscal first quarter, we remain focused on delivering cash cycle days in the low to mid 60s for fiscal 2027. Furthermore, we continue to expect to generate at least
Mr. Kelsey concluded, “We are guiding fiscal first quarter revenue of
| Quarterly & Annual Comparison | Three Months Ended | Twelve Months Ended | |||||||||||||||||
| (in thousands, except EPS) | Oct 3, 2026 | Jul 4, 2026 | Sep 27, 2025 | Oct 3, 2026 | Sep 27, 2025 | ||||||||||||||
| Revenue | $ | 1,426,570 | $ | 1,304,778 | $ | 1,058,366 | $ | 4,964,957 | $ | 4,032,966 | |||||||||
| Gross profit | 145,976 | 131,379 | 104,783 | 502,669 | 406,514 | ||||||||||||||
| Operating income | 86,276 | 61,260 | 53,112 | 263,837 | 202,371 | ||||||||||||||
| Net income | 68,506 | 42,993 | 51,429 | 202,490 | 172,885 | ||||||||||||||
| Diluted EPS | $ | 2.51 | $ | 1.58 | $ | 1.87 | $ | 7.41 | $ | 6.26 | |||||||||
| Gross margin | 10.2 | % | 10.1 | % | 9.9 | % | 10.1 | % | 10.1 | % | |||||||||
| Operating margin | 6.0 | % | 4.7 | % | 5.0 | % | 5.3 | % | 5.0 | % | |||||||||
| ROIC (1) | 15.8 | % | 14.9 | % | 14.6 | % | 15.8 | % | 14.6 | % | |||||||||
| Economic return (1) | 6.8 | % | 5.9 | % | 5.7 | % | 6.8 | % | 5.7 | % | |||||||||
| (1) Refer to Non-GAAP Supplemental Information tables for non-GAAP financial measures discussed and/or disclosed in this release, such as adjusted operating margin, adjusted net income, adjusted diluted EPS, ROIC and economic return. | |||||||||||||||||||
Business Segment and Market Sector Revenue
Plexus measures operational performance and allocates resources on a geographic segment basis. Plexus also reports revenue based on the market sector breakout set forth in the table below, which reflects Plexus’ market sector focused strategy. Top 10 customers comprised
| Business Segments ($ in millions) | Three Months Ended | Twelve Months Ended | |||||||||||||||||
| Oct 3, 2026 | Jul 4, 2026 | Sep 27, 2025 | Oct 3, 2026 | Sep 27, 2025 | |||||||||||||||
| Americas | $ | 456 | $ | 428 | $ | 336 | $ | 1,626 | $ | 1,217 | |||||||||
| Asia-Pacific | 861 | 774 | 605 | 2,898 | 2,393 | ||||||||||||||
| Europe, Middle East and Africa | 115 | 109 | 119 | 458 | 440 | ||||||||||||||
| Elimination of inter-segment sales | (5 | ) | (6 | ) | (2 | ) | (17 | ) | (17 | ) | |||||||||
| Total Revenue | $ | 1,427 | $ | 1,305 | $ | 1,058 | $ | 4,965 | $ | 4,033 | |||||||||
| Market Sectors ($ in millions) | Three Months Ended | Twelve Months Ended | ||||||||||||||||||||||
| Oct 3, 2026 | Jul 4, 2026 | Sep 27, 2025 | Oct 3, 2026 | Sep 27, 2025 | ||||||||||||||||||||
| Aerospace/Defense | $ | 224 | 16 | % | $ | 233 | 18 | % | $ | 173 | 16 | % | $ | 847 | 17 | % | $ | 689 | 17 | % | ||||
| Healthcare/Life Sciences | 512 | 36 | % | 483 | 37 | % | 424 | 40 | % | 1,933 | 39 | % | 1,629 | 40 | % | |||||||||
| Industrial | 691 | 48 | % | 589 | 45 | % | 461 | 44 | % | 2,185 | 44 | % | 1,715 | 43 | % | |||||||||
| Total Revenue | $ | 1,427 | $ | 1,305 | $ | 1,058 | $ | 4,965 | $ | 4,033 | ||||||||||||||
Non-GAAP Supplemental Information
Plexus provides non-GAAP supplemental information, such as ROIC, economic return and free cash flow, because such measures are used for internal management goals and decision-making, and because they provide management and investors with additional insight into financial performance. In addition, management uses these and other non-GAAP measures, such as adjusted operating income, adjusted operating margin, adjusted net income and adjusted diluted EPS, to provide a better understanding of core performance for purposes of period-to-period comparisons. Plexus believes that these measures are also useful to investors because they provide further insight by eliminating the effect of non-recurring items that are not reflective of continuing operations. For additional information on non-GAAP measures, please refer to the attached Non-GAAP Supplemental Information tables.
ROIC and Economic Return
ROIC for fiscal year 2026 was
Free Cash Flow
Plexus defines free cash flow as cash flows provided by operations less capital expenditures. For the three months ended October 3, 2026, cash flows provided by operations was
| Cash Cycle Days | Three Months Ended | ||||||
| Oct 3, 2026 | Jul 4, 2026 | Sep 27, 2025 | |||||
| Days in Accounts Receivable | 60 | 56 | 57 | ||||
| Days in Contract Assets | 13 | 13 | 13 | ||||
| Days in Inventory | 119 | 116 | 118 | ||||
| Days in Accounts Payable | (81) | (76) | (70) | ||||
| Days in Advanced Payments | (49) | (47) | (55) | ||||
| Annualized Cash Cycle (1) | 62 | 62 | 63 | ||||
| (1) Plexus calculates cash cycle as the sum of days in accounts receivable, days in contract assets and days in inventory, less days in accounts payable and days in advanced payments. | |||||||
Conference Call and Webcast Information
| What: | Plexus Fiscal Q4 and Fiscal Year 2026 Earnings Conference Call and Webcast |
| When: | Thursday, October 29, 2026 at 8:30 a.m. Eastern Time |
| Where: | Participants are encouraged to join the live webcast at the investor relations section of the Plexus website, plexus.com. Participants can also join utilizing the links below: Webcast link: https://events.q4inc.com/attendee/892821381 |
| Replay: | The webcast will be archived on the Plexus website and will be available as on-demand for 12 months |
Investor and Media Contact
Shawn Harrison
+1.920.969.6325
shawn.harrison@plexus.com
About Plexus
At Plexus, we help create the products that build a better world. Driven by a passion for excellence, we partner with our customers to design, manufacture and service highly complex products in demanding regulatory environments. From life-saving medical devices and mission-critical aerospace and defense products to a range of industrial products such as automation systems, robotics, power and energy management and semiconductor capital equipment, our innovative solutions span the lifecycle of a product and converge where advanced technology and human impact intersect. We provide these solutions to market-leading as well as disruptive companies globally in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial market sectors, supported by a global team of approximately 25,000 members across our 29 facilities. For more information about Plexus, visit our website at www.plexus.com.
Safe Harbor and Fair Disclosure Statement
The statements contained in this press release that are guidance or which are not historical facts (such as statements in the future tense and statements including believe, expect, intend, plan, anticipate, goal, target and similar terms and concepts), including all discussions of periods which are not yet completed, are forward-looking statements that involve risks and uncertainties. These risks and uncertainties include the effects of tariffs, trade disputes, trade agreements and other trade protection measures; the effects of shortages, delays and price fluctuations in obtaining components as a result of economic cycles, capacity constraints, natural disasters or otherwise; the risk of customer delays, changes, cancellations or forecast inaccuracies in both ongoing and new programs; the particular risks relative to new or recent customers, programs or services, which risks include customer and other delays, start-up costs, potential inability to execute, the establishment of appropriate engagement terms, and the lack of a track record of order volume and timing; the risk that new program wins and/or customer demand may not result in the expected revenue or profitability; the lack of visibility of future orders, particularly in view of changing economic conditions; the economic performance of the industries, sectors and customers we serve; the effects of the volume of revenue from certain sectors or programs on our margins in particular periods; our ability to secure new customers, maintain our current customers and deliver product on a timely basis; the risks of concentration of work for certain customers; the effects of start-up costs of new programs and facilities or the costs associated with winding down programs or the closure or consolidation of facilities; possible unexpected costs and operating disruption in transitioning programs, including transitions between Company facilities; the risks associated with excess and obsolete inventory, including the risk that inventory purchased on behalf of our customers may not be consumed or otherwise paid for by the customer, resulting in an inventory write-off; the fact that customer orders may not lead to long-term relationships; our ability to manage successfully and execute a complex business model characterized by high product mix and demanding quality, regulatory, and other requirements; the outcome of litigation and regulatory investigations and proceedings, including the results of any challenges with regard to such outcomes; the ability to realize anticipated savings from restructuring or similar actions, as well as the adequacy of related charges as compared to actual expenses; risks related to information technology systems and data security; increasing regulatory and compliance requirements; any tax law changes and related foreign jurisdiction tax developments; current or potential future barriers to the repatriation of funds that are currently held outside of the United States as a result of actions taken by other countries or otherwise; the potential effects of jurisdictional results on our taxes, tax rates, and our ability to use deferred tax assets and net operating losses; the weakness of the economy regionally or globally; the effect of changes in the pricing and margins of our services; raw materials and component cost fluctuations; the potential effect of fluctuations in the value of the currencies in which we transact business; the effects of changes in economic conditions, political conditions and regulatory matters in the United States and in the other countries in which we do business; the potential effect of other events outside our control, such as the conflict between Russia and Ukraine, conflict in the Middle East (including in Iran), escalating tensions between China and Taiwan or China and the United States, tensions in or amongst countries in which we operate or transact business; changes in energy prices, terrorism, global health epidemics and weather events; the impact of increased competition; an inability to successfully manage human capital, including succession planning for and transition of senior executives; changes in financial accounting standards; and other risks detailed herein and in our other Securities and Exchange Commission filings, particularly in Risk Factors contained in our fiscal 2025 Form 10-K.
| PLEXUS CORP. AND SUBSIDIARIES | |||||||||||||||
| CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | |||||||||||||||
| (in thousands, except per share data) | |||||||||||||||
| (unaudited) | |||||||||||||||
| Three Months Ended | Twelve Months Ended | ||||||||||||||
| Oct 3, | Sep 27, | Oct 3, | Sep 27, | ||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||
| Net sales | $ | 1,426,570 | $ | 1,058,366 | $ | 4,964,957 | $ | 4,032,966 | |||||||
| Cost of sales | 1,280,594 | 953,583 | 4,462,288 | 3,626,452 | |||||||||||
| Gross profit | 145,976 | 104,783 | 502,669 | 406,514 | |||||||||||
| Operating expenses: | |||||||||||||||
| Selling and administrative expenses | 59,700 | 51,671 | 238,832 | 199,460 | |||||||||||
| Restructuring and other charges, net | — | — | — | 4,683 | |||||||||||
| Operating income | 86,276 | 53,112 | 263,837 | 202,371 | |||||||||||
| Other income (expense): | |||||||||||||||
| Interest expense | (4,946 | ) | (2,413 | ) | (15,345 | ) | (11,605 | ) | |||||||
| Interest income | 1,098 | 883 | 4,357 | 3,922 | |||||||||||
| Miscellaneous, net | (1,952 | ) | (1,917 | ) | (7,015 | ) | (6,670 | ) | |||||||
| Income before income taxes | 80,476 | 49,665 | 245,834 | 188,018 | |||||||||||
| Income tax expense (benefit) | 11,970 | (1,764 | ) | 43,344 | 15,133 | ||||||||||
| Net income | $ | 68,506 | $ | 51,429 | $ | 202,490 | $ | 172,885 | |||||||
| Earnings per share: | |||||||||||||||
| Basic | $ | 2.57 | $ | 1.91 | $ | 7.58 | $ | 6.39 | |||||||
| Diluted | $ | 2.51 | $ | 1.87 | $ | 7.41 | $ | 6.26 | |||||||
| Weighted average shares outstanding: | |||||||||||||||
| Basic | 26,634 | 26,901 | 26,718 | 27,038 | |||||||||||
| Diluted | 27,242 | 27,444 | 27,328 | 27,616 | |||||||||||
| PLEXUS CORP. AND SUBSIDIARIES | |||||||
| CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||
| (in thousands) | |||||||
| (unaudited) | |||||||
| Oct 3, | Sep 27, | ||||||
| 2026 | 2025 | ||||||
| ASSETS | |||||||
| Current assets: | |||||||
| Cash and cash equivalents | $ | 281,176 | $ | 306,464 | |||
| Restricted cash | 45 | 294 | |||||
| Accounts receivable | 938,973 | 656,573 | |||||
| Contract assets | 193,753 | 150,654 | |||||
| Inventories | 1,674,611 | 1,229,839 | |||||
| Prepaid expenses and other | 74,049 | 54,969 | |||||
| Total current assets | 3,162,607 | 2,398,793 | |||||
| Property, plant and equipment, net | 559,180 | 546,052 | |||||
| Operating lease right-of-use assets | 66,328 | 72,863 | |||||
| Deferred income taxes | 115,229 | 91,349 | |||||
| Other assets | 30,593 | 28,053 | |||||
| Total non-current assets | 771,330 | 738,317 | |||||
| Total assets | $ | 3,933,937 | $ | 3,137,110 | |||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | |||||||
| Current liabilities: | |||||||
| Current portion of long-term debt and finance lease obligations | $ | 179,515 | $ | 45,793 | |||
| Accounts payable | 1,132,392 | 726,597 | |||||
| Advanced payments from customers | 690,608 | 575,850 | |||||
| Accrued salaries and wages | 125,020 | 109,076 | |||||
| Other accrued liabilities | 82,923 | 61,367 | |||||
| Total current liabilities | 2,210,458 | 1,518,683 | |||||
| Long-term debt and finance lease obligations, net of current portion | 81,236 | 91,987 | |||||
| Long-term operating lease liabilities | 23,053 | 29,422 | |||||
| Deferred income taxes | 7,506 | 6,000 | |||||
| Other liabilities | 38,576 | 36,430 | |||||
| Total non-current liabilities | 150,371 | 163,839 | |||||
| Total liabilities | 2,360,829 | 1,682,522 | |||||
| Shareholders’ equity: | |||||||
| Common stock | 549 | 547 | |||||
| Additional paid-in-capital | 719,529 | 695,653 | |||||
| Common stock held in treasury | (1,340,876 | ) | (1,255,451 | ) | |||
| Retained earnings | 2,198,518 | 1,996,028 | |||||
| Accumulated other comprehensive (loss) income | (4,612 | ) | 17,811 | ||||
| Total shareholders’ equity | 1,573,108 | 1,454,588 | |||||
| Total liabilities and shareholders’ equity | $ | 3,933,937 | $ | 3,137,110 | |||
| PLEXUS CORP. AND SUBSIDIARIES | |||||||
| CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||
| (in thousands) | |||||||
| (unaudited) | |||||||
| Twelve Months Ended | |||||||
| Oct 3, | Sep 27, | ||||||
| 2026 | 2025 | ||||||
| Cash flows from operating activities | |||||||
| Net income | $ | 202,490 | $ | 172,885 | |||
| Adjustments to reconcile net income to net cash flows from operating activities: | |||||||
| Depreciation and amortization | 77,025 | 77,792 | |||||
| Share-based compensation expense and related charges | 46,379 | 30,268 | |||||
| Deferred income tax benefit | (19,160 | ) | (16,300 | ) | |||
| Other, net | 495 | (6,556 | ) | ||||
| Changes in operating assets and liabilities, excluding impacts of currency: | |||||||
| Accounts receivable | (285,434 | ) | (30,749 | ) | |||
| Contract assets | (43,218 | ) | (29,678 | ) | |||
| Inventories | (447,684 | ) | 84,862 | ||||
| Other current and non-current assets | (23,048 | ) | 13,499 | ||||
| Accrued income taxes payable | 5,715 | (14,663 | ) | ||||
| Accounts payable | 417,461 | 98,644 | |||||
| Advanced payments from customers | 115,700 | (134,533 | ) | ||||
| Other current and non-current liabilities | 21,479 | 3,760 | |||||
| Cash flows provided by operating activities | 68,200 | 249,231 | |||||
| Cash flows from investing activities | |||||||
| Payments for property, plant and equipment | (97,137 | ) | (95,264 | ) | |||
| Other, net | (253 | ) | (347 | ) | |||
| Cash flows used in investing activities | (97,390 | ) | (95,611 | ) | |||
| Cash flows from financing activities | |||||||
| Borrowings under debt agreements | 896,500 | 477,000 | |||||
| Payments on debt and finance lease obligations | (785,057 | ) | (592,817 | ) | |||
| Debt issuance costs | (1,191 | ) | — | ||||
| Repurchases of common stock, including excise tax | (85,425 | ) | (65,336 | ) | |||
| Payments related to tax withholding for share-based compensation | (21,875 | ) | (15,251 | ) | |||
| Cash flows provided by (used in) financing activities | 2,952 | (196,404 | ) | ||||
| Effect of exchange rate changes on cash and cash equivalents | 701 | 2,080 | |||||
| Net decrease in cash and cash equivalents and restricted cash | (25,537 | ) | (40,704 | ) | |||
| Cash and cash equivalents and restricted cash: | |||||||
| Beginning of period | 306,758 | 347,462 | |||||
| End of period | $ | 281,221 | $ | 306,758 | |||
| PLEXUS CORP. AND SUBSIDIARIES | |||||||||||||||||||||
| NON-GAAP SUPPLEMENTAL INFORMATION Table 1 | |||||||||||||||||||||
| (in thousands, except per share data) | |||||||||||||||||||||
| (unaudited) | |||||||||||||||||||||
| Three Months Ended | Twelve Months Ended | ||||||||||||||||||||
| Oct 3, | Jul 4, | Sep 27, | Oct 3, | Sep 27, | |||||||||||||||||
| 2026 | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||
| Operating income, as reported | $ | 86,276 | $ | 61,260 | $ | 53,112 | $ | 263,837 | $ | 202,371 | |||||||||||
| Operating margin, as reported | 6.0 | % | 4.7 | % | 5.0 | % | 5.3 | % | 5.0 | % | |||||||||||
| Non-GAAP adjustments: | |||||||||||||||||||||
| Restructuring costs (1) | — | — | — | — | 4,683 | ||||||||||||||||
| Stock-based compensation (2) | 9,565 | 21,137 | 7,803 | 46,389 | 29,616 | ||||||||||||||||
| Non-GAAP operating income | $ | 95,841 | $ | 82,397 | $ | 60,915 | $ | 310,226 | $ | 236,670 | |||||||||||
| Non-GAAP operating margin | 6.7 | % | 6.3 | % | 5.8 | % | 6.2 | % | 5.9 | % | |||||||||||
| Net income, as reported | $ | 68,506 | $ | 42,993 | $ | 51,429 | $ | 202,490 | $ | 172,885 | |||||||||||
| Non-GAAP adjustments: | |||||||||||||||||||||
| Restructuring costs, net of tax (1) | — | — | — | — | 4,191 | ||||||||||||||||
| Stock-based compensation, net of tax (2) | 8,825 | 20,337 | 7,414 | 42,594 | 28,136 | ||||||||||||||||
| Adjusted net income | $ | 77,331 | $ | 63,330 | $ | 58,843 | $ | 245,084 | $ | 205,212 | |||||||||||
| Diluted earnings per share, as reported | $ | 2.51 | $ | 1.58 | $ | 1.87 | $ | 7.41 | $ | 6.26 | |||||||||||
| Non-GAAP per share adjustments: | |||||||||||||||||||||
| Restructuring costs, net of tax (1) | — | — | — | — | 0.15 | ||||||||||||||||
| Stock-based compensation, net of tax (2) | 0.33 | 0.74 | 0.27 | 1.56 | 1.02 | ||||||||||||||||
| Adjusted diluted earnings per share | $ | 2.84 | $ | 2.32 | $ | 2.14 | $ | 8.97 | $ | 7.43 | |||||||||||
| (1) | During the twelve months ended September 27, 2025, restructuring costs of | ||||||||||||||||||||
| (2) | During the three months ended October 3, 2026, During the three months ended July 4, 2026, During the twelve months ended October 3, 2026, | ||||||||||||||||||||
| PLEXUS CORP. AND SUBSIDIARIES | ||||||||||||||
| NON-GAAP SUPPLEMENTAL INFORMATION Table 2 | ||||||||||||||
| (in thousands) | ||||||||||||||
| (unaudited) | ||||||||||||||
| ROIC and Economic Return Calculations | Twelve Months Ended | Nine Months Ended | Twelve Months Ended | |||||||||||
| Oct 3, | Jul 4, | Sep 27, | ||||||||||||
| 2026 | 2026 | 2025 | ||||||||||||
| Operating income, as reported | $ | 263,837 | $ | 177,561 | $ | 202,371 | ||||||||
| Restructuring and other charges, net | — | — | 4,683 | |||||||||||
| Accelerated stock-based compensation (1) | + | 14,015 | + | 12,940 | + | — | ||||||||
| Adjusted operating income | $ | 277,852 | $ | 190,501 | $ | 207,054 | ||||||||
| ÷ | 3 | |||||||||||||
| $ | 63,500 | |||||||||||||
| x | 4 | |||||||||||||
| Adjusted annualized operating income | $ | 277,852 | $ | 254,000 | $ | 207,054 | ||||||||
| Adjusted effective tax rate | x | 17 | % | x | 16 | % | x | 8 | % | |||||
| Tax impact | 47,235 | 40,640 | 16,564 | |||||||||||
| Adjusted operating income (tax-effected) | $ | 230,617 | $ | 213,360 | $ | 190,490 | ||||||||
| Average invested capital | ÷ | $ | 1,461,798 | ÷ | $ | 1,431,266 | ÷ | $ | 1,303,575 | |||||
| ROIC | 15.8 | % | 14.9 | % | 14.6 | % | ||||||||
| Weighted average cost of capital | - | 9.0 | % | - | 9.0 | % | - | 8.9 | % | |||||
| Economic return | 6.8 | % | 5.9 | % | 5.7 | % | ||||||||
| Average Invested Capital Calculations | Oct 3, | Jul 4, | Apr 4, | Jan 3, | Sep 27, | ||||||||||||||
| 2026 | 2026 | 2026 | 2026 | 2025 | |||||||||||||||
| Equity | $ | 1,573,108 | $ | 1,528,752 | $ | 1,489,800 | $ | 1,481,063 | $ | 1,454,588 | |||||||||
| Plus: | |||||||||||||||||||
| Debt and finance lease obligations - current | 179,515 | 183,814 | 143,112 | 66,837 | 45,793 | ||||||||||||||
| Operating lease obligations - current (2) | 8,189 | 7,616 | 7,758 | 7,943 | 8,253 | ||||||||||||||
| Debt and finance lease obligations - long-term | 81,236 | 91,644 | 91,034 | 91,139 | 91,987 | ||||||||||||||
| Operating lease obligations - long-term | 23,053 | 23,888 | 25,769 | 27,327 | 29,422 | ||||||||||||||
| Less: Cash and cash equivalents | (281,176 | ) | (314,053 | ) | (303,133 | ) | (248,825 | ) | (306,464 | ) | |||||||||
| $ | 1,583,925 | $ | 1,521,661 | $ | 1,454,340 | $ | 1,425,484 | $ | 1,323,579 | ||||||||||
| Average Invested Capital Calculations | Jun 28, | Mar 29, | Dec 28, | Sep 28, | |||||||||||
| 2025 | 2025 | 2024 | 2024 | ||||||||||||
| Equity | $ | 1,419,085 | $ | 1,351,675 | $ | 1,319,069 | $ | 1,324,825 | |||||||
| Plus: | |||||||||||||||
| Debt and finance lease obligations - current | 50,678 | 121,014 | 121,977 | 157,325 | |||||||||||
| Operating lease obligations - current (2) | 8,470 | 9,968 | 14,875 | 14,697 | |||||||||||
| Debt and finance lease obligations - long-term | 92,215 | 88,761 | 88,728 | 89,993 | |||||||||||
| Operating lease obligations - long-term | 31,192 | 32,720 | 35,124 | 32,275 | |||||||||||
| Less: Cash and cash equivalents | (237,567 | ) | (310,531 | ) | (317,161 | ) | (345,109 | ) | |||||||
| $ | 1,364,073 | $ | 1,293,607 | $ | 1,262,612 | $ | 1,274,006 | ||||||||
| (1 | ) | During the twelve months ended October 3, 2026, During the nine months ended July 4, 2026, |
| (2 | ) | Included in other accrued liabilities on the Condensed Consolidated Balance Sheets. |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What were Plexus PLXS fiscal fourth-quarter 2026 earnings?
Plexus reported $1.427 billion in revenue and GAAP diluted EPS of $2.51 for the quarter ended October 3, 2026. GAAP operating margin was 6.0%. Adjusted diluted EPS was $2.84, excluding $0.33 of stock-based compensation expense.
What is Plexus PLXS guidance for fiscal first-quarter 2027?
Plexus forecasts revenue of $1.410 billion to $1.460 billion and GAAP diluted EPS of $2.16 to $2.32 for the quarter ending January 2, 2027. GAAP operating margin guidance is 5.5% to 5.9%. Adjusted EPS guidance is $2.46 to $2.62, excluding $0.30 of stock-based compensation expense.
Why was Plexus fiscal 2026 free cash flow negative?
Plexus generated $68.2 million in operating cash flow and spent $97.1 million on capital expenditures, resulting in $28.9 million of free cash flow usage. Free cash flow is operating cash flow less capital expenditures.